Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Advancing Recognition and Personalized Genetic Medicine for MODY in a Multi-Ethnic US Population
Host Immune Responses to Antigens of Malaria Parasites
Cortical circuit dysfunction in fragile x syndrome
The role of XIAP during cold ischemia and kidney transplantation.
Preclinical neuroprotective trials of a PPAR-gamma agonist in HD mouse models
Recently added grants:
Randomized Controlled Trial of Resistant Starch to Reduce Colon Cancer Risk in Alaska Native People
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)
Persistent transcriptional changes induced by nickel through epigenetic alterations
Artificial Intelligence for Assessment of Stargardt Macular Atrophy
Adaptive Optics Imaging of Human Retinal Vascular Structure and Function
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant